Headache and migraine in mitochondrial disease and its impact on life-results from a cross-sectional, questionnaire-based study.
Headache and migraine in mitochondrial disease and its impact on life-results from a cross-sectional, questionnaire-based study.
复制标题
DOI:
10.1007/s13760-021-01630-4
复制
发表时间:
2021-10
影响因子:
2.7
通讯作者:
Kraya T
中科院分区:
文献类型:
--
作者:
Burow P;Meyer A;Naegel S;Watzke S;Zierz S;Kraya T
Headache is frequent in patients with mitochondrial disorders. Previous studies point to a higher prevalence of headache in these patients than in the general population. As mitochondrial disorders often present a variety of other symptoms, the question arises how much the presence of headache really influences daily life. We performed a cross-sectional, questionnaire-based study investigation with 61 patients with a genetically proved mitochondrial disease mainly composed of CPEO phenotype. Headache was examined using a standardized questionnaire, and classified according to ICHD-2. Headache-related disability was evaluated by the Headache-Impact-Test-6 (HIT-6). Additionally, depression and anxiety were examined using the Hospital Anxiety and Depression Scale (HADS) and Short-Form-Health Survey (SF-12) was used to investigate the health-related quality of life. Headache was reported by 43/61 (70.5%) of the patients. 35/61 patients (57.4%) described a Tension-type headache (TTH) and 26 patients (42.6%) a migraine. Patients reporting headache had a significantly higher HIT-6 score than those without (mean: 54.47 vs. 38.47, p < 0.001). The HIT-6 score was significantly higher in patients reporting a migraine compared to those with a tension-type headache (mean: 62.13 vs. 46.18, p < 0.001). In the HADS score and in the SF-12 were not significantly influenced by the occurrence of headache. This study confirms the previously reported frequent occurrence of headache in a large cohort of patients with a confirmed mitochondrial disease. Migraine had the greatest impact on daily living, which appeared not to be confounded by depression and anxiety. Thus, we conclude that Migraine may be a substantial contributor for burden of disease in patients with mitochondrial diseases.
登录
查看更多内容
影响因子:
11.2
作者:
Gorman GS;Schaefer AM;Ng Y;Gomez N;Blakely EL;Alston CL;Feeney C;Horvath R;Yu-Wai-Man P;Chinnery PF;Taylor RW;Turnbull DM;McFarland R
通讯作者:
McFarland R
影响因子:
4.9
作者:
Vollono, Catello;Primiano, Guido;Servidei, Serenella
通讯作者:
Servidei, Serenella
影响因子:
3
作者:
Pfeffer, Gerald;Sirrs, Sandra;Mezei, Michelle M.
通讯作者:
Mezei, Michelle M.
影响因子:
7.4
作者:
Yoon, M-S;Katsarava, Z.;Obermann, M.;Fritsche, G.;Oezyurt, M.;Kaesewinkel, K.;Katsarova, A.;Santowski, I.;Diener, H.;Moebus, S.
通讯作者:
Moebus, S.
DOI:
10.1186/s10194-016-0649-2
发表时间:
2016
期刊:
The journal of headache and pain
影响因子:
--
作者:
Lampl C;Thomas H;Tassorelli C;Katsarava Z;Laínez JM;Lantéri-Minet M;Rastenyte D;Ruiz de la Torre E;Stovner LJ;Andrée C;Steiner TJ
通讯作者:
Steiner TJ